Filing Details

Accession Number:
0000950103-23-001415
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-01-30 19:23:01
Reporting Period:
2023-01-27
Accepted Time:
2023-01-30 19:23:01
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1356090 Precigen Inc. PGEN Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1724195 Helen Sabzevari 20374 Seneca Meadows Parkway
Germantown MD 20876
President And Ceo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-01-27 22,857 $1.75 937,613 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The reporting person purchased shares of Precigen common stock ("Common Stock") in connection with the issuer's follow-on offering, which closed on January 27, 2023. The purchase price is the offering price.